Berman Medical, Inc. — SEC Form D Filing

Berman Medical, Inc. filed an SEC Form D on June 24, 2026, reporting $607K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
June 24, 2026
Amount reported
$607K
Round stage
Pre-Seed
Industry
Medical Devices
Website
https://www.bermanmed.com/

What the company does

Securities: Simple Agreement for Future Equity (SAFE). Revenue: No Revenues. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Clinicians in dermatology using facial injections may lack real-time, patient-specific anatomical context, leading to treatments that are less predictable and personalized.

Solution

Berman Medical is building an aesthetics platform with a navigation system that provides real-time, patient-specific anatomical context for facial injections using advanced imaging, spatial tracking, and AI-powered planning.

Why now

Advances in medical imaging, spatial tracking, and AI allow for precise, real-time anatomical mapping, making sophisticated navigation systems for aesthetic procedures feasible and scalable.

Verdict

Investors backed this pre-seed round anticipating a first-mover advantage in precision aesthetics, betting on early adoption by high-volume clinics. This cleared because of the clear problem and buyer, not because of demonstrated technological defensibility or broad market expansion potential. The limited upside stemmed from the niche focus on a single aesthetic procedure type, hinting at a potentially shallow market ceiling if the technology did not expand beyond facial injections or if adoption proved slower than anticipated among established practitioners.

Source: SEC EDGAR Form D filing